SLS

SELLAS Life Sciences Group, Inc.

Company with tickers: SLS

Market Cap

$2.30B

Shares Outstanding

186,032,574

CIK

1390478

CUSIP

81642T209

13F Activity (30d)

8 filings 2 filers

Website

Visit website

Investor Relations

Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2013-06-30	$3,489,000	—	—	10-Q, filed 2013-08-09
2013-03-31	$3,489,000	—	—	10-Q, filed 2013-05-09
2012-12-31	$3,489,000	—	—	10-K, filed 2013-03-12
2012-09-30	$3,849,000	—	—	10-Q, filed 2012-11-13
2012-06-30	$3,849,000	—	—	10-Q, filed 2012-08-14
2012-03-31	$3,849,000	—	—	10-Q, filed 2012-05-14
2011-12-31	$3,849,000	—	—	10-K, filed 2012-03-28
2011-09-30	$3,849,000	—	—	10-Q, filed 2011-11-14
2011-06-30	$3,849,000	—	—	10-Q/A, filed 2011-10-28
2010-12-31	$3,849,000	—	—	10-K, filed 2012-03-28

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2013-06-30	$0 Δ	—	—	10-Q, filed 2013-08-09
2013-03-31	$0 Δ	—	—	10-Q, filed 2013-05-09
2012-09-30	$0 Δ	—	—	10-Q, filed 2012-11-13
2012-06-30	$0 Δ	—	—	10-Q, filed 2012-08-14
2012-03-31	$0 Δ	—	—	10-Q, filed 2012-05-14
2011-12-31	$0 Δ	—	—	10-K, filed 2012-03-28
2011-09-30	$0 Δ	—	—	10-Q, filed 2011-11-14
2010-12-31	$0 Δ	—	—	10-K, filed 2012-03-28
2010-09-30	$0 Δ	—	—	10-Q, filed 2011-11-14